Frontlight ResearchEarly access
Active, not recruitingNo phase
RETHINK REFLUX Registry
Key facts
- Who runs it
- Ethicon Endo-Surgery
- Where
- Allentown, Amarillo, Appleton, Columbus, Edgewood, Englewood, Greenville, Greenwood, Houston, Lancaster, Lansing, Los Angeles, Mobile, Peoria, Richmond, San Antonio, Seattle, Tampa, Tucson, and West Columbia, United StatesSee the 21 sitesAlso in 5 other countries, 7 sites
- Trial code
- Status
- Active, not recruiting
- People taking part
- 500 people enrolled
- Started
- 8 Jul 2020
- Expected to end
- 31 Jul 2032
- Type of study
- Observational
- Treatments tested
- LINX Reflux Management System
- Record updated
- 3 November 2026
Who can take part
- Age
- 21 years to 99 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 6 criteriaShow less
Who can take part
- Subject is >or=21 years old
- Subject with prospective plans for a LINX procedure
- Subject provides written informed consent
- Subject must be willing and able to complete questionnaires/ surveys electronically (ePROs)
Who cannot take part
- Subject who was previously implanted with LINX device
- Any reason which the Principal Investigator believes may cause the subject to be non-compliant with or unable to meet the protocol requirements (i.e. medical illness and/or limited life expectancy of less than 10 years); Note: Physicians should refer to the LINX Reflux Management System IFU for a complete list of contraindications, warnings, and precautions
Where in United States
Also in 5 other countries, 7 sites
- Lehigh Valley Hospital-Cedar CrestAllentown, United States
- Panhandle Weight Loss CenterAmarillo, United States
- Fox Valley Surgical AssociatesAppleton, United States
- The Ohio State UniversityColumbus, United States
- Saint Elizabeth Healthcare EdgewoodEdgewood, United States
- Institute of Esophageal and Reflux SurgeryEnglewood, United States
- East Carolina University / Vidant Medical CenterGreenville, United States
- Minimal Access Surgery/Prisma Health - UpstateGreenville, United States
- Adv Surg Assoc / Self Regional HealthcareGreenwood, United States
- Houston MethodistHouston, United States
- Gen Surg Assoc / Fairfield Medical CenterLancaster, United States
- Sparrow Hospital / Sparrow Medical GroupLansing, United States
- Keck Hospital of USCLos Angeles, United States
- University of South AlabamaMobile, United States
- OSF Medical GroupPeoria, United States
- Richmond Surg / Henrico Doctors' HospitalRichmond, United States
- Bariatric Medical Institute of TexasSan Antonio, United States
- Swedish Medical CenterSeattle, United States
- University of Southern Florida (Tampa General Hospital)Tampa, United States
- NW Allied Bariatric and Foregut SurgeryTucson, United States
- Lexington SurgeryWest Columbia, United States
About the trial
What the trial wants to find out
The RETHINK REFLUX Registry is a post-market prospective, multi-center, observation, single arm, long-term safety surveillance registry of subjects implanted with the LINX device. The primary objective of the study is to confirm the long-term safety profile of the LINX device and procedure (implant/explant) up to 10 years post-implant.
Treatments tested
- LINX Reflux Management System
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Research to Further Inform Thinking About the Role of LINX for Reflux Disease
- Record updated
- 3 November 2026